Conestoga Capital Advisors, LLC Chembio Diagnostics, Inc. Transaction History

Conestoga Capital Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 03, 2020	SELL	$3.18 - $15.54 $391,632 - $1.91 Million	-123,155 Closed	0 $0
Q1 2020 Apr 17, 2020	BUY	$2.36 - $5.6 $16,708 - $39,648	7,080 Added 6.1%	123,155 $631,000
Q4 2019 Jan 24, 2020	BUY	$3.94 - $5.76 $343,075 - $501,552	87,075 Added 300.26%	116,075 $529,000
Q3 2019 Oct 25, 2019	BUY	$4.84 - $7.25 $140,360 - $210,250	29,000 New	29,000 $177,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Conestoga Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Conestoga Capital Advisors, LLC with notifications on news.